Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_assertion type Assertion NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_head.
- NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_assertion description "[Plasma analyses revealed a significant increase in OPN and MMP-9 levels and activity in patients with prostate cancer in association with clinical variables (prostate-specific antigen > 4 ng/mL and Gleason score > 7).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_provenance.
- NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_assertion evidence source_evidence_literature NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_provenance.
- NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_assertion SIO_000772 19010864 NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_provenance.
- NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_assertion wasDerivedFrom befree-2016 NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_provenance.
- NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_assertion wasGeneratedBy ECO_0000203 NP703538.RABvWYFYrdzZxkZ1-XTNsNFt1rYeXmwBirStPQ3W_GlfE130_provenance.